Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Splenomegaly and MPL[original query] |
---|
CALR mutation screening in pediatric primary myelofibrosis. Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis. British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia. Blood cancer journal 2016 Oct 6 (10): e487. Haider M, Elala Y C, Gangat N, Hanson C A, Tefferi |
Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease. Leukemia research 2017 Jun 60 18-23. Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor |
The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology 2017 Feb . Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms. International journal of hematology 2018 Feb . Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor |
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Leukemia research 2018 Jan 65 42-48. Gángó Ambrus, Mózes Réka, Boha Zsófia, Kajtár Béla, Timár Botond, Király Péter Attila, Kiss Richárd, Fésüs Viktória, Nagy Noémi, Demeter Judit, Körösmezey Gábor, Borbényi Zita, Marton Imelda, Sz?ke Anita, Masszi Tamás, Farkas Péter, Várkonyi Judit, Plander Márk, Pósfai Éva, Egyed Miklós, Pál Katalin, Radványi Gáspár, Hamed Aryan, Csomor Judit, Matolcsy András, Alpár Donát, Bödör Csa |
Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran. Iranian journal of pathology 2018 13 (4): 397-402. Shams Seyyede Fatemeh, Ayatollahi Hossein, Sadeghian Mohammad Hadi, Afzalaghaee Monavar, Shakeri Sepideh, Yazdandoust Ehsan, Sheikhi Maryam, Amini Nafiseh, Bakhshi Samane, Bahrami Afsa |
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis. Leukemia 2020 6 35 (2): 468-475. Barosi Giovanni, Rosti Vittorio, Catarsi Paolo, Villani Laura, Abbà Carlotta, Carolei Adriana, Magrini Umberto, Gale Robert Peter, Massa Margherita, Campanelli Ri |
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American journal of hematology 2021 Aug . Loscocco Giuseppe G, Guglielmelli Paola, Gangat Naseema, Rossi Elena, Mannarelli Carmela, Betti Silvia, Maccari Chiara, Ramundo Francesco, Jadoon Yamna, Gesullo Francesca, Ceglie Sara, Paoli Chiara, Pardanani Animesh, De Stefano Valerio, Tefferi Ayalew, Vannucchi Alessandro |
[Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 1 41 (12): 989-995. Wu J Y, Li B, Jia Y J, Zhang P H, Xu Z F, Qin T J, Qu S Q, Pan L J, Liu J Q, Yan X, Zhang Y D, Chen J, Gong J Y, Xiao Z |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: